Rating History for Intersect ENT (XENT) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/12/2021 | Richard Newitter | Downgrade | Market Perform (Outperform) |
28.25 (N/A) |
28.01 (28.24) |
0.82% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
